2-Dose Vaccines Do Not Provide Enough Neutralizing Antibodies Against Omicron: Study
The two-dose formulations of the Pfizer and AstraZeneca vaccines were found to be not that effective in fighting off the newly emerged variant.
Read Original Article: 2-Dose Vaccines Do Not Provide Enough Neutralizing Antibodies Against Omicron: Study »
